Regulon

Regulon: R-1035

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
36-1.1335910Pr-134Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
54455 ENSG00000037637 FBXO42 X6RKU3
6047 ENSG00000063978 RNF4 P78317
55205 ENSG00000074657 ZNF532 Q9HCE3
9733 ENSG00000075856 SART3 Q15020
8555 ENSG00000081377 CDC14B O60729
79728 ENSG00000083093 PALB2 Q86YC2
51729 ENSG00000084463 WBP11 Q9Y2W2
8898 ENSG00000087053 MTMR2 A0A6Q8PGT1
11198 ENSG00000092201 SUPT16H Q9Y5B9
10291 ENSG00000099995 SF3A1 Q15459
22938 ENSG00000100603 SNW1 Q13573
23394 ENSG00000101126 ADNP Q9H2P0
22919 ENSG00000101367 MAPRE1 Q15691
23347 ENSG00000101596 SMCHD1 A6NHR9
10240 ENSG00000102738 MRPS31 Q92665
55756 ENSG00000104299 INTS9 Q9NV88
642 ENSG00000108578 BLMH Q13867
1665 ENSG00000109606 DHX15 O43143
6418 ENSG00000119335 SET Q01105
5894 ENSG00000132155 RAF1 A0A8I5KR46
3178 ENSG00000135486 HNRNPA1 P09651
55316 ENSG00000136444 RSAD1 Q9HA92
5495 ENSG00000138032 PPM1B O75688
25800 ENSG00000141424 SLC39A6 Q13433
142 ENSG00000143799 PARP1 P09874
51631 ENSG00000146963 LUC7L2 Q9Y383
1105 ENSG00000153922 CHD1 O14646
5529 ENSG00000154001 PPP2R5E Q16537
22976 ENSG00000157212 PAXIP1 Q6ZW49
23358 ENSG00000162402 USP24 Q9UPU5
26130 ENSG00000165219 GAPVD1 Q14C86
5747 ENSG00000169398 PTK2 E5RH01
171023 ENSG00000171456 ASXL1 Q8IXJ9
30849 ENSG00000196455 PIK3R4 Q99570
10137 ENSG00000244462 RBM12 Q9NTZ6
10236 ENSG00000282958 HNRNPR O43390

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
RUCAPARIBPARP1Small moleculeINHIBITORPARP 1, 2 and 3 inhibitor40
PAMIPARIBPARP1Small moleculeINHIBITORPoly [ADP-ribose] polymerase-1 inhibitor31
XL-281RAF1Small moleculeINHIBITORSerine/threonine-protein kinase RAF inhibitor20
GSK-2256098PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor20
LADIRATUZUMAB VEDOTINTUBB1AntibodyINHIBITORTubulin inhibitor20
SORAFENIB TOSYLATEPDGFRBSmall moleculeINHIBITORStem cell growth factor receptor inhibitor42
BI-853520PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
MLN-2480RAF1Small moleculeINHIBITORRAF serine/threonine protein kinase inhibitor10
OLAPARIBPARP1Small moleculeINHIBITORPARP 1, 2 and 3 inhibitor42
SORAFENIBFLT3Small moleculeINHIBITORStem cell growth factor receptor inhibitor42
TALAZOPARIBPARP1Small moleculeINHIBITORPoly [ADP-ribose] polymerase 2 inhibitor42
VS-4718PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
DEFACTINIBPTK2BSmall moleculeINHIBITORFocal adhesion kinase 1 inhibitor20
RUCAPARIB CAMSYLATEPARP1Small moleculeINHIBITORPARP 1, 2 and 3 inhibitor40
VELIPARIBPARP1Small moleculeINHIBITORPARP 1, 2 and 3 inhibitor32
ARQ-736RAF1Small moleculeINHIBITORSerine/threonine-protein kinase RAF inhibitor10
2X-121TNKS2Small moleculeINHIBITORPoly [ADP-ribose] polymerase-1 inhibitor20
NIRAPARIBPARP2Small moleculeINHIBITORPoly [ADP-ribose] polymerase 2 inhibitor42
LY-3009120ARAFSmall moleculeINHIBITORSerine/threonine-protein kinase A-Raf inhibitor10
LXH254RAF1Small moleculeINHIBITORB-raf/RAF proto-oncogene serine/threonine-protein kinase inhibitor20
NIRAPARIB TOSYLATEPARP1Small moleculeINHIBITORPoly [ADP-ribose] polymerase 2 inhibitor40
CEP-37440ALKSmall moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
TALAZOPARIB TOSYLATEPARP1Small moleculeINHIBITORPoly [ADP-ribose] polymerase 2 inhibitor40
REGORAFENIBKDRSmall moleculeINHIBITORTyrosine-protein kinase TIE-2 inhibitor42
CONTELTINIBPTK2Small moleculeINHIBITORProtein tyrosine kinase 2 beta inhibitor10
BELVARAFENIBRAF1Small moleculeINHIBITORRAF serine/threonine protein kinase inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1035

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs